Harvard Bioscience, reporting a small decline in second-quarter revenues, said it would exploit its database of more than 150,000 academics in an effort to increase sales.

The firm also disclosed that it has engaged investment banking firm Thomas Weisel Partners to help it find a buyer for the capital equipment segment, which includes the struggling Genomic Solutions business. The company said it would use proceeds from the sale to pay down a $15.2 million debt facility and finance tuck-in acquisitions for the apparatus business.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.